|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Talukdar FR, Ghosh SK, Laskar RS and
Mondal R: Epigenetic, genetic and environmental interactions in
esophageal squamous cell carcinoma from northeast India. PLoS One.
8:e609962013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedberg EC: A history of the DNA repair
and mutagenesis field: I. The discovery of enzymatic
photoreactivation. DNA Repair. 33:35–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gan GN, Wittschieben JP, Wittschieben BO
and Wood RD: DNA polymerase zeta (pol ζ) in higher eukaryotes. Cell
Res. 18:174–183. 2008. View Article : Google Scholar
|
|
6
|
Knobel PA, Kotov IN, Felley-Bosco E,
Stahel RA and Marti TM: Inhibition of REV3 expression induces
persistent DNA damage and growth arrest in cancer cells. Neoplasia.
13:961–970. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang S, Chen H, Zhao X, Cao J, Tong J, Lu
J, Wu W, Shen H, Wei Q and Lu D: REV3L 3′UTR 460 T>C
polymorphism in microRNA target sites contributes to lung cancer
susceptibility. Oncogene. 32:242–250. 2013. View Article : Google Scholar
|
|
8
|
Varadi V, Bevier M, Grzybowska E,
Johansson R, Enquist K, Henriksson R, Butkiewicz D, Pamula-Pilat J,
Tecza K, Hemminki K, et al: Genetic variation in genes encoding for
polymerase ζ subunits associates with breast cancer risk, tumour
characteristics and survival. Breast Cancer Res Treat. 129:235–245.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Shi T, Liu F, Ren C, Wang Z, Li Y,
Tu X, Yang G and Cheng X: REV3L, a promising target in regulating
the chemosensitivity of cervical cancer cells. PLoS One.
10:e01203342015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi TY, Yang L, Yang G, Tu XY, Wu X, Cheng
X and Wei Q: DNA polymerase ζ as a potential biomarker of
chemoradiation resistance and poor prognosis for cervical cancer.
Med Oncol. 30:5002013. View Article : Google Scholar
|
|
11
|
Kawamura K, O-Wang J, Bahar R, Koshikawa
N, Shishikura T, Nakagawara A, Sakiyama S, Kajiwara K, Kimura M and
Tagawa M: The error-prone DNA polymerase ζ catalytic subunit (Rev3)
gene is ubiquitously expressed in normal and malignant human
tissues. Int J Oncol. 18:97–103. 2001.
|
|
12
|
Xiao W, Lechler T, Chow BL, Fontanie T,
Agustus M, Carter KC and Wei YF: Identification, chromosomal
mapping and tissue-specific expression of hREV3 encoding a putative
human DNA polymerase ζ. Carcinogenesis. 19:945–949. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brondello JM, Pillaire MJ, Rodriguez C,
Gourraud PA, Selves J, Cazaux C and Piette J: Novel evidences for a
tumor suppressor role of Rev3, the catalytic subunit of Pol ζ.
Oncogene. 27:6093–6101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Zhang SY, Wang S, Lu J, Wu W, Weng
L, Chen D, Zhang Y, Lu Z, Yang J, et al: REV3L confers
chemoresistance to cisplatin in human gliomas: The potential of its
RNAi for synergistic therapy. Neuro Oncol. 11:790–802. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Zhang S, Xie L, Liu P, Xie F, Wu
J, Cao J and Ding WQ: Overexpression of DNA polymerase iota (Polι)
in esophageal squamous cell carcinoma. Cancer Sci. 103:1574–1579.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Waters LS, Minesinger BK, Wiltrout ME,
D'Souza S, Woodruff RV and Walker GC: Eukaryotic translesion
polymerases and their roles and regulation in DNA damage tolerance.
Microbiol Mol Biol Rev. 73:134–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibbs PE, McGregor WG, Maher VM, Nisson P
and Lawrence CW: A human homolog of the Saccharomyces cerevisiae
REV3 gene, which encodes the catalytic subunit of DNA polymerase ζ.
Proc Natl Acad Sci USA. 95:6876–6880. 1998. View Article : Google Scholar
|
|
18
|
Gueranger Q, Stary A, Aoufouchi S, Faili
A, Sarasin A, Reynaud CA and Weill JC: Role of DNA polymerases η, ι
and ζ in UV resistance and UV-induced mutagenesis in a human cell
line. DNA Repair. 7:1551–1562. 2008. View Article : Google Scholar
|
|
19
|
Hicks JK, Chute CL, Paulsen MT, Ragland
RL, Howlett NG, Guéranger Q, Glover TW and Canman CE: Differential
roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of
intrastrand versus interstrand DNA cross-links. Mol Cell Biol.
30:1217–1230. 2010. View Article : Google Scholar :
|
|
20
|
Sarbia M, Stahl M, Fink U, Heep H,
Dutkowski P, Willers R, Seeber S and Gabbert HE: Prognostic
significance of cyclin D1 in esophageal squamous cell carcinoma
patients treated with surgery alone or combined therapy modalities.
Int J Cancer. 84:86–91. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Diehl JA: Cycling to cancer with cyclin
D1. Cancer Biol Ther. 1:226–231. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jares P, Colomer D and Campo E: Genetic
and molecular pathogenesis of mantle cell lymphoma: Perspectives
for new targeted therapeutics. Nat Rev Cancer. 7:750–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thomas GR, Nadiminti H and Regalado J:
Molecular predictors of clinical outcome in patients with head and
neck squamous cell carcinoma. Int J Exp Pathol. 86:347–363. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 8:61–70. 2008.
View Article : Google Scholar
|
|
25
|
Kato J, Kuwabara Y, Mitani M, Shinoda N,
Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, et al:
Expression of survivin in esophageal cancer: Correlation with the
prognosis and response to chemotherapy. Int J Cancer. 95:92–95.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Feng J, Chen X, Guo W, Du Y, Wang
Y, Zang W, Zhang S and Zhao G: Myricetin enhance chemosensitivity
of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.
Cancer Cell Int. 14:712014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pinedo HM and Peters GF: Fluorouracil:
Biochemistry and pharmacology. J Clin Oncol. 6:1653–1664.
1988.PubMed/NCBI
|
|
28
|
Bijnsdorp IV, Peters GJ, Temmink OH,
Fukushima M and Kruyt FA: Differential activation of cell death and
autophagy results in an increased cytotoxic potential for
trifluorothymidine compared to 5-fluorouracil in colon cancer
cells. Int J Cancer. 126:2457–2468. 2010.
|
